Amedeo Smart

Free Medical Literature Service

 

Amedeo

Nuclear Medicine
  Free Subscription

Articles published in
J Neuroimaging
    January 2024
  1. ATHANASIO BS, Oliveira ACS, Pedrosa AL, Borges RS, et al
    The role of brain perfusion SPECT in the diagnosis of frontotemporal dementia: A systematic review.
    J Neuroimaging. 2024 Jan 8. doi: 10.1111/jon.13189.
    >> Share

    December 2023
  2. BISHAY S, Robb WH, Schwartz TM, Smith DS, et al
    Frontal and anterior temporal hypometabolism post chemoradiation in head and neck cancer: A real-world PET study.
    J Neuroimaging. 2023 Dec 26. doi: 10.1111/jon.13181.
    >> Share

  3. KONERU M, Hoseinyazdi M, Lakhani DA, Greene C, et al
    Redefining CT perfusion-based ischemic core estimates for the ghost core in early time window stroke.
    J Neuroimaging. 2023 Dec 25. doi: 10.1111/jon.13180.
    >> Share

    November 2023
  4. OZDEN C, Mautner VF, Farschtschi S, Molwitz I, et al
    Asymmetry of thalamic hypometabolism on FDG-PET/CT in neurofibromatosis type 1: Association with peripheral tumor burden.
    J Neuroimaging. 2023 Nov 9. doi: 10.1111/jon.13170.
    >> Share

    September 2023
  5. LU W, Yao F, Yin C, Wan S, et al
    Computed tomography perfusion software pipelines to assess parameter maps and ischemic volumes: A comparative study.
    J Neuroimaging. 2023 Sep 22. doi: 10.1111/jon.13154.
    >> Share

    June 2023
  6. YEDAVALLI V, Hamam O, Mohseni A, Chen K, et al
    Pretreatment brain CT perfusion thresholds for predicting final infarct volume in distal medium vessel occlusions.
    J Neuroimaging. 2023 Jun 25. doi: 10.1111/jon.13142.
    >> Share

  7. MORBELLI S, Gambella M, Raiola AM, Ghiggi C, et al
    Brain FDG-PET findings in chimeric antigen receptor T-cell therapy neurotoxicity for diffuse large B-cell lymphoma.
    J Neuroimaging. 2023 Jun 8. doi: 10.1111/jon.13135.
    >> Share

    May 2023
  8. OHMURA K, Ikegame Y, Yano H, Shinoda J, et al
    Methionine-PET to differentiate between brain lesions appearing similar on conventional CT/MRI scans.
    J Neuroimaging. 2023 May 28. doi: 10.1111/jon.13126.
    >> Share

  9. OHMURA K, Kumagai N, Kumagai M, Ikegame Y, et al
    Combining methionine-PET and MRI fluid-attenuated inversion-recovery mismatch to determine glioma molecular subtype.
    J Neuroimaging. 2023 May 9. doi: 10.1111/jon.13114.
    >> Share

    March 2023
  10. SAWAMURA S, Ikegame Y, Kawasaki T, Nakayama N, et al
    Brainstem volume, diffusion, and metabolism are associated with chronic consciousness disorders after traumatic brain injury.
    J Neuroimaging. 2023;33:310-317.
    >> Share

    February 2023
  11. MORELLI N, Immovilli P, Giacopazzi E, Rota E, et al
    CT perfusion extended window ischemic core estimation: Bayesian algorithm versus oscillation index singular value decomposition.
    J Neuroimaging. 2023 Feb 13. doi: 10.1111/jon.13090.
    >> Share

    December 2022
  12. WOYK K, Sahlmann CO, Hansen N, Timaus C, et al
    Brain (18) F-FDG-PET and an optimized cingulate Island ratio to differentiate lewy body dementia and Alzheimer's disease.
    J Neuroimaging. 2022 Dec 5. doi: 10.1111/jon.13068.
    >> Share

    November 2022
  13. CERSONSKY TEK, Mechery S, Thompson L, Lee A, et al
    Related amyloid burden and cortical atrophy in individuals with subtle cognitive decline.
    J Neuroimaging. 2022;32:1075-1079.
    >> Share

    October 2022
  14. GALIANA A, Ruiz S, Alen JF, Gomez Grande A, et al
    Effects of cranioplasty in cerebral blood perfusion using quantification with 99m-Tc HMPAO SPECT-CT.
    J Neuroimaging. 2022 Oct 17. doi: 10.1111/jon.13058.
    >> Share

  15. KHALILI N, Wang R, Garg T, Ahmed A, et al
    Clinical application of brain perfusion imaging in detecting stroke mimics: A review.
    J Neuroimaging. 2022 Oct 7. doi: 10.1111/jon.13061.
    >> Share

    May 2022
  16. FILICE S, Pavarani A, Cerasti D
    Real-time assessment of individual optimal CT perfusion acquisition time in patients with ischemic stroke.
    J Neuroimaging. 2022 May 17. doi: 10.1111/jon.13004.
    >> Share

    April 2022
  17. JAKIMOVSKI D, Zivadinov R, Bergsland N, Oh J, et al
    Multisite MRI reproducibility of lateral ventricular volume using the NAIMS cooperative pilot dataset.
    J Neuroimaging. 2022 Apr 5. doi: 10.1111/jon.12998.
    >> Share

    December 2021
  18. MISHRA S, Suh CH, Bergmark RW, Jo VY, et al
    Imaging features, therapies, and outcomes of fibrosing inflammatory pseudotumor of the nasopharynx: A systematic review.
    J Neuroimaging. 2021 Dec 8. doi: 10.1111/jon.12953.
    >> Share

    November 2021
  19. HALLER S, Davidsson A, Tisell A, Ochoa-Figueroa M, et al
    MRI of nigrosome-1: A potential triage tool for patients with suspected parkinsonism.
    J Neuroimaging. 2021 Nov 1. doi: 10.1111/jon.12944.
    >> Share

    October 2021
  20. CHO KH, Park KM, Lee HJ, Cho H, et al
    Metabolic network is related to surgical outcome in temporal lobe epilepsy with hippocampal sclerosis: A brain FDG-PET study.
    J Neuroimaging. 2021 Oct 22. doi: 10.1111/jon.12941.
    >> Share

    August 2021
  21. AGHOURIAN M, Aumont E, Grothe MJ, Soucy JP, et al
    FEOBV-PET to quantify cortical cholinergic denervation in AD: Relationship to basal forebrain volumetry.
    J Neuroimaging. 2021 Aug 31. doi: 10.1111/jon.12921.
    >> Share

  22. PURANIK AD, Rangarajan V, Dev ID, Jain Y, et al
    Brain FET PET tumor-to-white mater ratio to differentiate recurrence from post-treatment changes in high-grade gliomas.
    J Neuroimaging. 2021 Aug 13. doi: 10.1111/jon.12914.
    >> Share

  23. LIU J, Lin C, Minuti A, Lipton M, et al
    Arterial spin labeling compared to dynamic susceptibility contrast MR perfusion imaging for assessment of ischemic penumbra: A systematic review.
    J Neuroimaging. 2021 Aug 13. doi: 10.1111/jon.12913.
    >> Share

    July 2021
  24. LEIGH R, Hitomi E, Hutchison RM, Elkins J, et al
    Post-stroke blood-brain barrier disruption predicts poor outcome in patients enrolled in the ACTION study.
    J Neuroimaging. 2021;31:751-757.
    >> Share

    June 2021
  25. ISHIBASHI K, Miura Y, Wagatsuma K, Kameyama M, et al
    Brain (11) C-ITMM PET to longitudinally assess type 1 metabotropic glutamate receptor availability in Alzheimer's disease.
    J Neuroimaging. 2021 Jun 18. doi: 10.1111/jon.12895.
    >> Share

    May 2021
  26. LIU D, Cheng G, Ma X, Wang S, et al
    PET/CT using (68) Ga-PSMA-617 versus (18) F-fluorodeoxyglucose to differentiate low- and high-grade gliomas.
    J Neuroimaging. 2021 May 22. doi: 10.1111/jon.12856.
    >> Share

  27. HEIT JJ, Christensen S, Mlynash M, Marks MP, et al
    MR perfusion imaging: Half-dose gadolinium is half the quality.
    J Neuroimaging. 2021 May 18. doi: 10.1111/jon.12879.
    >> Share

  28. MONGAY-OCHOA N, Sala-Padro J, Reynes-Llompart G, Rodriguez-Bel L, et al
    Brain FDG-PET findings in glutamic acid decarboxylase antibody-associated epilepsy.
    J Neuroimaging. 2021 May 6. doi: 10.1111/jon.12874.
    >> Share

  29. YAGHI S, Havenon A, Honda T, Hinman JD, et al
    Impaired Distal Perfusion Predicts Length of Hospital Stay in Patients with Symptomatic Middle Cerebral Artery Stenosis.
    J Neuroimaging. 2021;31:475-479.
    >> Share

    December 2020
  30. SZTURM T, Beheshti I, Mahana B, Hobson DE, et al
    Imaging Cerebral Glucose Metabolism during Dual-Task Walking in Patients with Parkinson's disease.
    J Neuroimaging. 2020 Dec 8. doi: 10.1111/jon.12812.
    >> Share

    November 2020
  31. SEE AP, Stapleton CJ, Du X, Charbel FT, et al
    Perfusion-MRI is a Poor Indicator of Hemodynamic Compromise in Vertebrobasilar Disease in the VERiTAS Study.
    J Neuroimaging. 2020 Nov 4. doi: 10.1111/jon.12802.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016